We are live on ! Find out more
THTX

Theratechnologies

Delisted

THTX was delisted on the 25th of September, 2025.

33 hedge funds and large institutions have $23.6M invested in Theratechnologies in 2024 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 9 increasing their positions, 7 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

150% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 2

29% more repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 7

10% more funds holding

Funds holding: 3033 (+3)

17% less capital invested

Capital invested by funds: $28.3M → $23.6M (-$4.73M)

41.17% less ownership

Funds ownership: 72.16%30.99% (-41%)

Holders
33
Holders Change
+3
Holders Change %
+10%
% of All Funds
0.48%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
5
Increased
9
Reduced
7
Closed
2
Calls
$20K
Puts
Net Calls
+$20K
Net Calls Change
+$20K

THTX Hedge Fund Activity: Q1 2024 in Review

33 of the 6,943 institutional investors tracked by Wall St. Rank reported a position in Theratechnologies (THTX) for Q1 2024, worth a combined $23.6M — down 17% from $28.3M a quarter earlier.

Buyers outnumbered sellers: 5 funds opened new THTX positions and 2 closed out — a net gain of 3 holders — while 9 added to existing stakes and 7 trimmed.

The largest buyer was Summit Trail Advisors, opening a new position worth an estimated $53.1K. The largest seller was Morgan Stanley, cutting an estimated $3.64M.

  • 33 institutional investors held Theratechnologies (THTX) as of Q1 2024, up from 30 in Q4 2023.
  • Funds reported $23.6M of Theratechnologies stock for Q1 2024, down 17% quarter-over-quarter.
  • 5 funds opened new Theratechnologies positions in Q1 2024 and 2 closed out, a net change of +3 holders.
  • The largest Theratechnologies buyer in Q1 2024 was Summit Trail Advisors, an estimated $53.1K added.
  • The largest Theratechnologies seller in Q1 2024 was Morgan Stanley, an estimated $3.64M sold.

Based on aggregated 13F filings for Q1 2024.